Featured GVCC 2021 Sessions
As a physician, Kristen has seen both tragedies and miracles in her career. As a caregiver and human, she has personally survived the loss of three family members, two to cancer. Now serving as Senior Vice President of Early Clinical Development, Hematology/Oncology & Cell Therapy at Bristol Myers Squibb (BMS), she and her team investigate new ways to transform patients’ lives through science on a daily basis. In this session, we will learn why patients are at the core of everything Kristen and her team do at BMS and hear how unique patient perspectives are helping to inform scientific discoveries. We will leave this session with a renewed understanding of the power of innovative medicines to profoundly change the course of serious human diseases, as well as BMS’ commitment to increase access and involve patients in improving care.
In the last decade, immuno-oncology treatments have transformed cancer care and brought new hope to millions of cancer patients. By harnessing the power of each person’s own immune system, immunotherapy has created new treatment options distinctly different from traditional methods. In this session, we will learn what immunotherapy is, how it works and where research is headed for the future. We will leave this session with a better understanding of immunotherapy, including vocabulary to discuss this treatment option with your oncologist.
Caregivers are undercounted, unheard, and all but invisible. They often sacrifice their health, deal with emotional isolation and lack time to care for themselves. This issue is compounded when a caregiver is a woman or a racial/ethnic minority due to the inherent inequities in our economic system and pressure from traditional family paradigms. In this session, we will discuss how we, as a society and individuals, can support caregivers to address their emotional and physical needs and create systems where we proactively help the helpers.
Masks. Susceptibility to viruses. Cancer survivors have lived through their traumatic times of health vulnerability. Now - throw a global pandemic layer on top of that. In this session, we will learn how cancer survivors should navigate the world with a virus that is not likely to disappear. We will leave this session with actionable tips cancer survivors and caregivers can utilize in their own lives to maintain a state of health well-being.
Being an ally and selecting a community is an ever-evolving process. Maybe there is a community that works for you, or you’re involved in a community that only meets half of your needs, or you haven’t found one yet. As we move along our journeys, our needs and interests will change - and so will the organizations we both support and support us. In this session, we will cover what it means to look through the “allyship” lens when choosing an organization and how to be a good ally for underserved communities. We will leave this session with the knowledge that your own needs are unique and how to filter communities in a way that works for you.
Clinical trials should embrace health equity, not serve as a barrier to it. In this session, we will hear how industry sponsors are approaching clinical trials with a move towards ensuring diverse representation, inclusion of patient voice, and how technology is enabling more access to patient research. We will leave this session with a better understanding of how trial sponsors are bringing the clinical trial journey to patients’ doorsteps.